Science Explorer Back to mapMap
Discussion
Researcher · Monash University · Australia

Jamie Rossjohn

Jamie Rossjohn publishes mostly in Immunology, Molecular Biology and Epidemiology, on topics such as Immune Cell Function and Interaction, T-cell and B-cell Immunology and Immunotherapy and Immune Responses.

ORCID 0000-0002-2020-7522 OpenAlex
World rank
#31,555
of 7,710,434 ranked researchers
Rank in Australia
#893
of 140,210
Works
987
Citations
50k
Citations per work
50.7
h-index
121
i10-index 480Top 0.2% in Immunology
Jamie Rossjohn

What does Jamie Rossjohn research?

Jamie Rossjohn's work is mostly in Immunology and Microbiology (50%), Medicine (19%), Biochemistry, Genetics and Molecular Biology (10%).

Life Sciences: 598 works · 60.6% of their workImmunology and Microbiology: 498 works · 50.5% of their workImmunology: 498 works · 50.5% of their workBiochemistry, Genetics and Molecular Biology: 100 works · 10.1% of their workMolecular Biology: 100 works · 10.1% of their workEverything else: 205 works · 20.8% of their workHealth Sciences: 184 works · 18.6% of their workMedicine: 184 works · 18.6% of their workEpidemiology: 68 works · 6.9% of their workOncology: 45 works · 4.6% of their workInfectious Diseases: 38 works · 3.8% of their workRadiology, Nuclear Medicine and Imaging: 33 works · 3.3% of their workTHEIR WORKJamie Rossjohn987works
Life Sciences61%Health Sciences19%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology49850.5%
    2. Biochemistry, Genetics and Molecular Biology10010.1%
  2. Everything else20520.8%
    1. Medicine18418.6%
  1. 1Immunology50% of their works
  2. 2Molecular Biology10% of their works
  3. 3Epidemiology7% of their works
  4. 4Oncology5% of their works
  5. 5Infectious Diseases4% of their works
  6. 6Radiology, Nuclear Medicine and Imaging3% of their works

Research topics

Which keywords describe Jamie Rossjohn's research?

The keywords of their largest research topics: Natural Killer Cells, NK Cell Recognition, Foxp3, TGF-ß, Cancer Immunotherapy, Antigen Presentation, Dendritic Cells and Immunity.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. NK Cell Recognition3891 topic
  2. Natural Killer Cells3891 topic
  3. Foxp33471 topic
  4. TGF-ß3471 topic
  5. Cancer Immunotherapy2322 topics
  6. Antigen Presentation2242 topics
  7. Dendritic Cells1701 topic
  8. Immunity1701 topic
  9. Fc Receptors651 topic
  10. Therapeutic Antibodies651 topic
  11. CAR T Cells621 topic
  12. Chimeric Antigen Receptor621 topic
  13. Cytomegalovirus561 topic
  14. Infection561 topic
  15. Epitope Prediction541 topic
  16. Peptide-MHC Binding541 topic
  17. Influenza301 topic
  18. Virus301 topic

Where does Jamie Rossjohn work?

Jamie Rossjohn's main affiliation in the publication record is Monash University, Australia.

How many publications and citations does Jamie Rossjohn have?

OpenAlex counts 987 works and 50,055 citations for Jamie Rossjohn, an h-index of 121, ranking #31,555 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jamie Rossjohn. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.